We are live on
!
Find out more
EIM
Essex Investment Management Portfolio holdings
AUM
$632M
1-Year Est. Return
95.36%
This Fund
S&P 500
This Quarter
Est. Return
+11.96%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$736M
AUM Growth
+$37.1M
(+5.3%)
Cap. Flow
-$23M
Cap. Flow
% of AUM
-3.13%
Top 10 Holdings %
Top 10 Hldgs %
19.12%
Holding
398
New
58
Increased
68
Reduced
185
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$5.4M |
| 2 |
Alibaba
BABA
|
+$4.84M |
| 3 |
Gilead Sciences
GILD
|
+$4.8M |
| 4 |
Teradyne
TER
|
+$4.28M |
| 5 |
EVBG
Everbridge, Inc. Common Stock
EVBG
|
+$3.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CYBR
CyberArk
CYBR
|
+$10.8M |
| 2 |
KITE
Kite Pharma, Inc.
KITE
|
+$7.32M |
| 3 |
Apple
AAPL
|
+$6.48M |
| 4 |
Walt Disney
DIS
|
+$5.46M |
| 5 |
Amazon
AMZN
|
+$4.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.04% |
| 2 | Healthcare | 17.67% |
| 3 | Industrials | 14.13% |
| 4 | Consumer Discretionary | 12.41% |
| 5 | Financials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INST
251
DELISTED
Instructure, Inc.
INST
| $600K | 0.08% |
18,087
+10,023
| +124% | +$310K |
|
|
ADAP
252
DELISTED
Adaptimmune Therapeutics
ADAP
| $598K | 0.08% |
72,996
-119,049
| -62% | -$743K |
|
|
AVEO
253
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $550K | 0.07% |
+15,062
| New | +$466K |
|
254
Electromed
ELMD
$352M
| $547K | 0.07% |
74,885
+44,931
| +150% | +$294K |
|
255
Weibo
WB
$1.91B
| $541K | 0.07% |
5,471
+1,121
| +26% | +$98.8K |
|
256
Range Resources
RRC
$9.39B
| $511K | 0.07% |
+26,119
| New | +$505K |
|
257
TechnipFMC
FTI
$29.5B
| $507K | 0.07% |
24,383
-1,136
| -4% | -$22.8K |
|
|
MTLS
258
Materialise
MTLS
$393M
| $504K | 0.07% |
+34,635
| New | +$469K |
|
|
NEWR
259
DELISTED
New Relic, Inc.
NEWR
| $500K | 0.07% |
10,031
+1,025
| +11% | +$48.4K |
|
260
American Express
AXP
$232B
| $498K | 0.07% |
5,500
| – | – |
|
|
CBMX
261
DELISTED
CombiMatrix Corporation
CBMX
| $496K | 0.07% |
66,070
+40,192
| +155% | +$273K |
|
262
Parke Bancorp
PKBK
$409M
| $493K | 0.07% |
+26,868
| New | +$451K |
|
|
RADA
263
DELISTED
Rada Electronic Industries Ltd
RADA
| $493K | 0.07% |
+144,552
| New | +$366K |
|
264
Campbell Soup
CPB
$6.74B
| $490K | 0.07% |
10,456
| – | – |
|
|
BOLD
265
DELISTED
Audentes Therapeutics, Inc
BOLD
| $490K | 0.07% |
+17,481
| New | +$380K |
|
266
BioLife Solutions
BLFS
$1.71B
| $484K | 0.07% |
+84,755
| New | +$352K |
|
267
Bristol-Myers Squibb
BMY
$130B
| $483K | 0.07% |
7,584
-16,092
| -68% | -$940K |
|
268
Acuity Brands
AYI
$10.8B
| $478K | 0.07% |
2,792
| – | – |
|
|
JASN
269
DELISTED
Jason Industries, Inc.
JASN
| $477K | 0.06% |
300,141
+182,310
| +155% | +$225K |
|
|
ONCE
270
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $472K | 0.06% |
5,298
-5,536
| -51% | -$420K |
|
|
NFX
271
DELISTED
Newfield Exploration
NFX
| $472K | 0.06% |
15,901
-849
| -5% | -$22.8K |
|
272
Allegion
ALLE
$14.1B
| $467K | 0.06% |
5,395
-1,354
| -20% | -$109K |
|
273
DLH Holdings
DLHC
$67.8M
| $466K | 0.06% |
71,887
+43,043
| +149% | +$255K |
|
274
Genasys
GNSS
$77.4M
| $456K | 0.06% |
214,278
+128,284
| +149% | +$218K |
|
275
Check Point Software Technologies
CHKP
$13.2B
| $455K | 0.06% |
3,991
-315
| -7% | -$34.6K |
|
Similar funds
AMM
BI
KCMH
SFM
VIM
AP
TTSTC
WCM
Essex Investment Management's Q3 2017 Portfolio in Review
As of Q3 2017, Essex Investment Management held 398 positions worth $736M, up 5.3% from $699M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Essex Investment Management withdrew a net $23M in Q3 2017, closing 45 positions and reducing 185 holdings. Its most notable exit was CyberArk, an estimated $10.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Essex Investment Management opened a new position in Teradyne worth $4.61M.
- Essex Investment Management's largest Q3 2017 buy was Teradyne: 123,552 shares worth $4.61M.
- Essex Investment Management added most to Home Depot in Q3 2017, an estimated $5.4M increase.
- Essex Investment Management's biggest Q3 2017 reduction was Apple, cutting an estimated $6.48M.
- Essex Investment Management fully exited CyberArk in Q3 2017, selling an estimated $10.8M.
- Essex Investment Management's ten largest holdings make up 19% of its $736M portfolio in Q3 2017.
- Essex Investment Management opened 58 new positions and closed 45 in Q3 2017.
- Essex Investment Management's portfolio value rose 5.3% quarter-over-quarter to $736M.
Based on Essex Investment Management's 13F filing for Q3 2017, filed 30 Oct 2017.